# FDA Inspection 1215469 - Louisville Reproductive Center - August 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/f493a94c-3444-481c-95aa-3884b9108ec7
Source feed: FDA_Inspections

> FDA Inspection 1215469 for Louisville Reproductive Center on August 22, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215469
- Company Name: Louisville Reproductive Center
- Inspection Date: 2023-08-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1268429 - 2025-04-28](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/98c29722-5505-4871-93d3-0e802fff7729)
- [FDA Inspection 1215469 - 2023-08-22](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/f6d2adbc-dd73-4aba-b108-a45d69750d8d)
- [FDA Inspection 1172027 - 2022-06-14](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/2ff5ac27-7905-491d-bf36-fb621c6860f7)
- [FDA Inspection 1172027 - 2022-06-14](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/0c338ff1-aedc-4f5f-94d4-b91d10bd056c)
- [FDA Inspection 1172027 - 2022-06-14](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/4488df10-a08d-42b2-9256-e892f646514a)

Company: https://www.keypedia.com/companies/louisville-reproductive-center/b1b4afdf-389d-463a-9b58-d06525fee135

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d